Skin infections encompass a diverse range of conditions caused by bacteria, viruses, fungi, or parasites. Common bacterial skin infections include impetigo, cellulitis, and folliculitis, often presenting with redness, swelling, and pus formation. Viral infections like herpes simplex and warts affect the skin, causing characteristic lesions. Fungal infections, such as ringworm and athlete's foot, thrive in warm and moist environments. Parasitic infections like scabies, caused by mites, lead to intense itching and skin irritation. Proper hygiene, wound care, and avoiding contact with infectious agents are essential preventive measures. Treatment may involve topical or oral antibiotics, antifungal medications, or antiparasitic drugs, depending on the causative agent. Infections can range from mild and self-limiting to severe and potentially life-threatening. Timely diagnosis and appropriate management are crucial to prevent complications and reduce the spread of contagious skin conditions. Ongoing research explores novel therapies, antimicrobial resistance, and public health strategies to address the diverse challenges posed by skin infections.
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Post COVID-19 syndrome is associated with sex and severity of first COVID-19 episode in Honduras
Manuel Antonio Sierra Santos, Central American Technological University, Honduras
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Development of a platform UPLC-CAD method for high-throughput lipid quantitation and characterization in novel mRNA LNPs
Janet Muzulu, Sanofi, United States